Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. (March 2023) - Abd-ellatef, Gamal Eldein Fathy; Gazzano, Elena; El-Desoky, Ahmed H.; Hamed, Ahmed R.; Kopecka, Joanna; Belisario, Dimas Carolina; Costamagna, Costanzo; Marie, Mohamed Assem S.; Fahmy, Sohair R.; Abdel-Hamid, Abdel-Hamid Z.; Riganti, Chiara